Global Spirometer Market Report and Forecast 2024-2032

Global Spirometer Market Outlook

The global spirometer market size was valued at USD 1,161.1 million in 2023, driven by the increasing prevalence of respiratory diseases across the globe. The market size is anticipated to grow at a CAGR of 8.31% during the forecast period of 2024-2032 to achieve a value of USD 2,371.2 million by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Spirometer Market Overview

A spirometer is a handheld tool used to examine lung capacity by measuring the volume of air inhaled and exhaled by the lungs. Spirometers help diagnose breathing issues, be it cough, shortness of breath, or mucus production. Spirometry tests should be avoided in situations such as active tuberculosis, coughing of blood, and pneumothorax, among other complications.

The increasing prevalence of chronic obstructive pulmonary disease is subjected to an increase in the demand for diagnostics and monitoring equipment such as spirometers, fueling the spirometer market growth. Developments are being carried out in spirometer technology to simplify operations and reduce the complications involved in pulmonary function testing procedures. New designs with improved features are expected to increase the demand for spirometers in the forecast period.

Innovating packaging methods are being adopted by companies to avoid bacterial or other infections between users, making it safer to use by patients in the long term. Spirometers are often recommended by doctors to patients’ post-surgery to monitor lung performance and general breathing conditions. The rising use of spirometers in hospital settings and the homes of people with breathing issues is another key trend influencing the market.

Rising Prevalence of Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries. COPD is the seventh leading cause of poor health worldwide (measured by disability-adjusted life years). Tobacco smoking accounts for over 70% of COPD cases in high-income countries. In low- and middle-income countries, tobacco smoking accounts for 30–40% of COPD cases, and household air pollution is a major risk factor.  The spirometer market demand may experience significant growth owing to the rising prevalence of COPD across the low- and middle-income countries.

Increasing Product Launches in the Market

In August 2023, A breakthrough in COPD assessment was launched nationwide for the regulated AI technology for COPD, which uses the N-Tidal device. The technology combines N-Tidal’s high-resolution CO2 sensor data with an artificial intelligence platform that measures changes in lung function that might point toward a diagnosis of COPD. The ground-breaking medical tool can indicate a patient’s risk of COPD within minutes.

The nationwide launch of regulated AI technology for COPD, utilizing the N-Tidal device, is poised to significantly impact the global spirometer market by providing a rapid and advanced solution for assessing COPD risk. The ability to quickly indicate COPD risk may drive increased demand for such innovative spirometry technologies worldwide, contributing to the spirometer market share.

Rise in FDA Approvals to Aid the Market

In September 2023, Alveofit (Roundworks Technologies) received approval from the US Food and Drug Administration (FDA) for its portable digital spirometer, alveoair. The company aims to start the distribution of the product in the US followed by this approval. It also claimed that along with the FDA approval, an alliance with AstraZeneca will expand its international business, particularly in the US and emerging economies. The CDSCO-certified alveoair is allegedly India’s first US FDA-cleared spirometer and is adopted by more than 400 healthcare facilities across India. In India, alveofit partnered with various companies, including NASSCOM COE, Forge Innovation & Ventures, PATH, DST, and the India Sweden Innovation Centre.

The global spirometer market growth is anticipated to be driven by this FDA approval for alveoair spirometer, coupled with an alliance with AstraZeneca. The approval will enable product distribution in the US, fostering international growth, especially in the US and emerging economies. The product's integration into alveofit's ecosystem, providing real-time insights and predictive analytics, enhances respiratory care and positions the company for expanded market influence.

Increase in Research Activities

In 2023, NuvoAir presented a research study entitled ‘Quality and adherence of home spirometry in a remote respiratory physiologist-led assessment’ at the Association for Respiratory Technology and Physiology (ARTP) Annual Conference in Brighton. The poster outlined results from a retrospective analysis of NuvoAir’s 12-week Asthma Assessment Service in the UK and its impacts on the accurate diagnosis, management, and treatment of respiratory disease.

NuvoAir's research suggests that combining home assessment programs with remote physiologist support improves respiratory disease diagnosis and treatment. This advancement may boost global spirometer demand, driving growth in the market during the forecast period.

Additionally, In April 2023, Bogdan’s research team harnessed the power of artificial intelligence (AI) by sharing the findings from a study in the research paper entitled ‘Fractional Dynamics Foster Deep Learning of COPD Stage Prediction’. It was emphasized by the company that the device determines a diagnosis with 98.5% accuracy. The device is a wearable patch usually on the arm, embedded with a sensor. The device monitors 12 signal records such as the respiratory inductance plethysmography (RIP), which signals breathing efforts, and the wireless pulse-oximeter, which signals oxygen saturation levels while the doctor completes the normal physiological exam on the patient. In addition to this increased accuracy, this new device makes COPD diagnosis and monitoring easier. This AI-powered spirometer system, offering rapid and accurate COPD diagnosis with its cost-effectiveness, remote monitoring capabilities, and potential for widespread use, is expected to support the global spirometer market growth, challenging traditional models, and expanding accessibility to respiratory care.

Global Initiatives to Provide Significant Impetus

The market is poised to be influenced by global initiatives to curb the prevalence of non-communicable diseases such as the inclusion of COPD in the WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) and the United Nations 2030 Agenda for Sustainable Development. WHO is taking action to extend the diagnosis of and treatment for COPD in several ways. The WHO Package of Essential Noncommunicable Disease Interventions (PEN) was developed to help improve NCD management in primary health care in low-resource settings.

The inclusion of COPD in WHO's global health initiatives, such as the Global Action Plan and Rehabilitation 2030, could drive increased demand for spirometers globally. As WHO focuses on extending diagnosis and treatment, the spirometer market is expected to witness significant growth due to the rising importance of managing chronic respiratory diseases.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Spirometer Market Segmentations

Market Breakup by Product Type

• Devices

• Software

• Consumables and Accessories

Market Breakup by Technology

• Volume Measurement

• Flow Measurement

Market Breakup by Application

• Asthma

• COPD

• Fibrosis

• Other Applications

Market Breakup by End User

• Hospitals

• Clinical Laboratories

• Home Care Settings

• Other Applications

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Spirometer Market Regional Analysis

Considering the geographical landscape, North America is leading the market. The market is expected to dominate in the forecast period due to factors such as the increasing number of asthma and COPD cases. Due to the rise in these cases, the region has experienced a significant boost in the usage of spirometers, aiding disease control by doctors in hospitals. The market is further influenced by increasing research studies poised to bring innovation to the market.

For instance, in January 2023, Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, launched a clinical study comparing the treatment effect between at-home mobile spirometry using digital biomarkers and in-clinic spirometry in patients with moderate asthma on long-acting beta-agonist (LABA) treatment. This study may influence the global spirometer market by shaping preferences toward digital solutions . If proven effective, it may drive increased adoption of digital biomarker-based spirometry, impacting market growth during the forecast period.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Spirometer Market: Competitor Landscape

In January 2023, CAIRE Inc., the leading global manufacturer of oxygen therapy and on-site generation systems acquired Minnesota-based MGC Diagnostics Holdings, Inc. (MGC). This acquisition strengthens CAIRE’s position and focus on diagnostic technologies further expanding its expertise in serving patients throughout the progression of pulmonary disease.

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• MGC Diagnostic Corporation

• Teleflex Incorporated

• SCHILLER AG

• Vyaire medical

• Midmark Corporation

• Smiths Medical, Inc.

• Nspire Health Inc.

• COSMED srl

• Hill-Rom, Inc.

• Vitalograph

• Fukuda Sangyo

• Fysiomed

• Sibelmed

• Jones Medical Instrument Company

• Medriko

• Contec Medical Systems Co. Ltd.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report